Affiliation:
1. Princess Margaret Hospital, Hong Kong SAR, People’s Republic of China
Abstract
Introduction: Sarcosinaemia is a rare metabolic disorder which has not been reported in Asia.
Clinical Picture: The urine samples of 2 patients were screened as a routine metabolic screening offered for patients with mental retardation in our hospital. We used gas chromatography-mass spectrometry (GC-MS) which is capable of detecting abnormal pattern in amino acids and organic acids. Plasma sarcosine level was further quantified by GC-MS. The same methods were used in the investigations of asymptomatic family members. Urine examination by GC-MS revealed excessive amount of sarcosine in urine (normally undetectable) and their plasma sarcosine levels were raised. The 2 differential diagnoses of presence of sarcosine in urine – glutaric aciduria type II and folate deficiency – were ruled out by the absence of abnormal organic acids in the initial urine screen and by normal serum folate level respectively. Screening of the 2 families identified excessive sarcosine in urine in 2 siblings, one from each family. However, these 2 siblings of indexed patients thus identified have no neurological or developmental problem.
Conclusion: Our finding was consistent with the notion that sarcosinaemia is a benign condition picked up coincidentally during screening for mental retardation.
Key words: Gas chromatography-mass spectrometry, Hypersacosinaemia, Sarcosine, Sarcosine dehydrogenase
Publisher
Academy of Medicine, Singapore
Reference12 articles.
1. Levy HL, Coulombe JT, Benjamin R. Massachusetts Metabolic DisordersScreening Programme: III. Sarcosinemia. Pediatrics 1984;74:509-13.
2. Kuhara T. Diagnosis and monitoring of inborn errors of metabolismusing urease-pretreatment of urine, isotope dilution, and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002;781:497-517.
3. Brunialti AL, Harding CO, Wolff JA, Guenet JL. The mouse mutationsarcosinemia (sar) maps to chromosome 2 in a region homologous to human 9q33-q34. Genomics 1996;36:182-4.
4. Scott CR. Sarcosinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D,editors. The Metabolic and Molecular Basis of Inherited Disease. 8th ed. 584 A Benign Metabolic Condition— Shing-Yan Lee et al New York: McGraw-Hill, 2001:2057-64.
5. Gerritsen T, Waisman HA. Hypersarcosinemia: an inborn error ofmetabolism. N Engl J Med 1966;275:66-9.